Syros Pharmaceuticals, Inc.
SYRSDelisted Mar 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001556263
Syros Pharmaceuticals, Inc. was delisted on Mar 10, 2025; its insiders filed their last Form 4 on Dec 4, 2024; 44 institutions reported holding it in 13F filings for Q4 2024, worth $1.20M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Syros Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 69 | 53 | −16 |
| SharesConverted for a 1-for-10 split | 3.56M | 9.31M | +5.75M (+161.8%) |
| Value | $34.2M | $59.9M | +$25.7M (+75.1%) |
New holders (14)
Institutions that held Syros Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Avidity Partners Management LP | 900,000 | $5.80M | 0.13% |
| CVI Holdings, LLC | 425,500 | $2.74M | 0.21% |
| DAFNA Capital Management LLC | 265,878 | $1.71M | 0.46% |
| Dimensional Fund Advisors LP | 29,524 | $190.0K | 0.00% |
| Pathstone Family Office, LLC | 21,913 | $141.1K | 0.00% |
| Walleye Capital LLC | 12,800 | $82.0K | 0.00% |
| Edmond de Rothschild Holding S.A. | 4,382 | $28.0K | 0.00% |
| The PNC Financial Services Group, Inc. | 1,095 | $7.00K | 0.00% |
| Fifth Third Bancorp | 129 | $1.00K | 0.00% |
| Signaturefd, LLC | 87 | $1.00K | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1.00K | 0.00% |
| Bogart Wealth, LLC | 15 | $0 | 0.00% |
| Heritage Wealth Management, LLC | 18 | $0 | 0.00% |
| China Universal Asset Management Co., Ltd. | 59 | $0 | 0.00% |
Sold out (30)
Institutions that held Syros Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.